Spectranetics (SPNC) Misses Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Spectranetics Achieves First Quarter 2015 Revenue of $57.4 Million
April 23, 2015 4:03 PM EDTExpands Stellarex Program to Below the Knee Market
Updates 2015 Outlook
COLORADO SPRINGS, Colo., April 23, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq: SPNC) today reported financial results for the three months ended March 31, 2015. Highlights of the quarter, all compared with the three months ended March 31, 2014 include:
Revenue of $57.4 million, up 45% (47% constant currency1) Vascular Intervention revenue of $36.5 million grew 82% (84% constant currency) U.S. peripheral atherectomy revenue grew 16% AngioSculpt® revenue of $14.0 million achieved Lead Management revenue of $16.4 million increased 14% (16% constant... More
